T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
Public ClinicalTrials.gov record NCT03530696. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm Phase II Study to Evaluate Efficacy of T-DM1 With Palbociclib in the Treatment of Patients With Metastatic HER2 Positive Breast Cancer
Study identification
- NCT ID
- NCT03530696
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Arizona
- Other
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- Palbociclib Drug
- T-DM1 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 5, 2018
- Primary completion
- Dec 21, 2022
- Completion
- Dec 21, 2022
- Last update posted
- Aug 12, 2024
2018 – 2022
United States locations
- U.S. sites
- 16
- U.S. states
- 15
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Cedar-Sinai | Beverly Hills | California | 90048 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Yale Cancer Center | New Haven | Connecticut | 06519 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Mosaic Life Care | Saint Joseph | Missouri | 65406 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| Roswell Park Comprehensive Cancer center | Buffalo | New York | 14263 | — |
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health and Sciences University | Portland | Oregon | 97239 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| JPS Health Network | Fort Worth | Texas | 76104 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| University of Washington | Seattle | Washington | 98195 | — |
| University of Wisconsin | Madison | Wisconsin | 53706 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03530696, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2024 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03530696 live on ClinicalTrials.gov.